Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Genetics

• Publication date

  2012-06-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00439-012-1182-2PMID 22661295PMCID PMC3956317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Negative androgen-response elements mediate androgen-dependent transcriptional inhibition of TGF-β1 and CDK2 promoters in the prostate gland.

  2012cited by this paper
• Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples

  2011cited by this paper
• Current status of genome-wide association studies in cancer

  2011cited by this paper
• Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundant.

  2011cited by this paper
• The rules of DNA recognition by the androgen receptor.

  2010cited by this paper
• Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis

  2010influential reference
• Mutation-associated fusion cancer genes in solid tumors

  2009cited by this paper
• Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.

  2009influential reference
• SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.

  2009cited by this paper
• Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility

  2009cited by this paper
• A role for MEIS1 in MLL-fusion gene leukemia.

  2009cited by this paper
• Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

  2008cited by this paper
• EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

  2008cited by this paper
• Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males.

  2008cited by this paper
• Multiple newly identified loci associated with prostate cancer susceptibility

  2008cited by this paper
• Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70.

  2008cited by this paper
• A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells

  2008cited by this paper
• Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.

  2008cited by this paper
• Multiple loci identified in a genome-wide association study of prostate cancer

  2008cited by this paper
• EML4-ALK fusion lung cancer: a rare acquired event.

  2008cited by this paper
• Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

  2007cited by this paper
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

  2007cited by this paper
• Prominent use of distal 5' transcription start sites and discovery of a large number of additional exons in ENCODE regions.

  2007cited by this paper
• Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical Prostatectomy

  2007cited by this paper
• Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

  2007cited by this paper
• Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy

  2006cited by this paper
• Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

  2006cited by this paper
• AceView: a comprehensive cDNA-supported gene and transcripts annotation

  2006cited by this paper
• Alternative trans‐splicing: a novel mode of pre‐mRNA processing

  2006cited by this paper
• Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders

  2005cited by this paper
• Tandem chimerism as a means to increase protein complexity in the human genome.

  2005cited by this paper
• Transcription-mediated gene fusion in the human genome.

  2005influential reference
• Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer

  2004cited by this paper
• Epidemiology of prostate cancer.

  2003cited by this paper
• Chromosome translocations: dangerous liaisons revisited

  2001cited by this paper
• Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.

  1999cited by this paper
• An imprinted, mammalian bicistronic transcript encodes two independent proteins.

  1999cited by this paper
• Information analysis of human splice site mutations

  1998influential reference
• Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.

  1996cited by this paper
• Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells.

  1996cited by this paper
• Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.

  1994cited by this paper
• Chromosomal translocations in human cancer

  1994cited by this paper
• Identification of a functional androgen response element in the promoter of the gene for the androgen-regulated aldose reductase-like protein specific to the mouse vas deferens.

  1994cited by this paper

• Suggesting Tissue-Specific MSMB Gene Promoter as a Novel Approach for Prostate Targeted Gene Therapy

  2022cites this paper
• Basal Cell Carcinoma of Prostate With MSMB–NCOA4 Fusion and a Probable Basal Cell Carcinoma In Situ: Case Report

  2021cites this paper
• Nicotinic acetylcholine gene cluster CHRNA5-A3-B4 variants influence smoking status in a Bangladeshi population

  2021cites this paper
• HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation

  2021cites this paper
• Discovery and Characterization of Cancer Genetic Susceptibility Alleles

  2020cites this paper
• Overview of research on fusion genes in prostate cancer

  2020cites this paper
• An RNAi Screen for Genes Required for Growth of Drosophila Wing Tissue

  2019cites this paper
• A meta-analysis of influence of MSMB promoter rs10993994 polymorphisms on prostate cancer risk.

  2019cites this paper
• Evaluating gene fusions in solid tumors - Clinical experience using an RNA based 53 gene next-generation sequencing panel.

  2019cites this paper
• Robust Sample-Specific Stability Selection with Effective Error Control

  2019cites this paper
• Structural and molecular biology of PSP94: Its significance in prostate pathophysiology.

  2018cites this paper
• From Gene to Therapy: Understanding Human Disease through Genetics

  2017cites this paper
• Functional relevance of the candidate genes MSMB , NCOA 4 , TIMM 23 and PARG in the prostate cancer risk region 10 q 11 for the emergence of oncogenic TMPRSS 2 : ERG fusions

  2016cites this paper
• Hereditary Prostate Cancer

  2016cites this paper
• Genetic predisposition to prostate cancer.

  2016cites this paper
• Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer

  2016cites this paper
• A Unified Framework for the Prioritization of Variants of Uncertain Significance in Hereditary Breast and Ovarian Cancer Patients

  2015cites this paper
• Multiple criteria optimization joint analyses of microarray experiments in lung cancer: from existing microarray data to new knowledge

  2015cites this paper
• The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects

  2015cites this paper
• Prostate Cancer Genetics: A Review

  2015cites this paper
• Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis

  2014cites this paper
• Facteurs de risques génétiques associés à la patho-biologie du vieillissement prostatique

  2014cites this paper
• Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population

  2014cites this paper
• Role of β-microseminoprotein from prostate cancer initiation to recurrence: A mini-review

  2014cites this paper
• Genetics and genomics of prostate cancer.

  2013cites this paper
• ICP: A novel approach to predict prognosis of prostate cancer with inner-class clustering of gene expression data

  2013cites this paper
• Genome-wide association studies on prostate cancer: the end or the beginning?

  2013cites this paper